MX2023009052A - Compuesto de bifenilo como inmunomodulador, método de preparación para el mismo y uso del mismo. - Google Patents
Compuesto de bifenilo como inmunomodulador, método de preparación para el mismo y uso del mismo.Info
- Publication number
- MX2023009052A MX2023009052A MX2023009052A MX2023009052A MX2023009052A MX 2023009052 A MX2023009052 A MX 2023009052A MX 2023009052 A MX2023009052 A MX 2023009052A MX 2023009052 A MX2023009052 A MX 2023009052A MX 2023009052 A MX2023009052 A MX 2023009052A
- Authority
- MX
- Mexico
- Prior art keywords
- preparation
- method therefor
- immunomodulator
- compound
- biphenyl compound
- Prior art date
Links
- -1 Biphenyl compound Chemical class 0.000 title abstract 2
- 235000010290 biphenyl Nutrition 0.000 title abstract 2
- 239000004305 biphenyl Substances 0.000 title abstract 2
- 239000002955 immunomodulating agent Substances 0.000 title abstract 2
- 229940121354 immunomodulator Drugs 0.000 title abstract 2
- 230000002584 immunomodulator Effects 0.000 title abstract 2
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N phenylbenzene Natural products C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 title abstract 2
- 238000002360 preparation method Methods 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 238000010521 absorption reaction Methods 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003384 small molecules Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/43—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
- C07C211/44—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to only one six-membered aromatic ring
- C07C211/49—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to only one six-membered aromatic ring having at least two amino groups bound to the carbon skeleton
- C07C211/50—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to only one six-membered aromatic ring having at least two amino groups bound to the carbon skeleton with at least two amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
Un compuesto de bifenilo como se muestra en la fórmula (I), un método de preparación para el mismo y uso del mismo, y una composición farmacéutica que comprende el compuesto como principio activo. El compuesto es un inmunomodulador de molécula pequeña novedoso que tiene excelentes características de absorción oral y puede usarse para tratar y/o prevenir diversas enfermedades relacionadas con el sistema inmunitario.(ver formula).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110137428 | 2021-02-01 | ||
PCT/CN2022/074183 WO2022161421A1 (zh) | 2021-02-01 | 2022-01-27 | 作为免疫调节剂的联苯类化合物及其制备方法和应用 |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2023009052A true MX2023009052A (es) | 2023-10-16 |
Family
ID=82653005
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2023009052A MX2023009052A (es) | 2021-02-01 | 2022-01-27 | Compuesto de bifenilo como inmunomodulador, método de preparación para el mismo y uso del mismo. |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP4286383A1 (es) |
JP (1) | JP2024505972A (es) |
KR (1) | KR20230141812A (es) |
CN (1) | CN116710445A (es) |
AU (1) | AU2022214735A1 (es) |
BR (1) | BR112023015451A2 (es) |
CA (1) | CA3210314A1 (es) |
MX (1) | MX2023009052A (es) |
TW (1) | TWI814226B (es) |
WO (1) | WO2022161421A1 (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11866452B2 (en) * | 2020-10-29 | 2024-01-09 | Shenzhen Chipscreen Biosciences Co., Ltd. | Biphenyl compound as immunomodulator, preparation method therefor and application thereof |
WO2023207933A1 (zh) * | 2022-04-26 | 2023-11-02 | 深圳微芯生物科技股份有限公司 | 一种作为免疫调节剂的联苯类化合物的晶型及其制备方法 |
TW202346308A (zh) * | 2022-04-26 | 2023-12-01 | 大陸商深圳微芯生物科技股份有限公司 | 作為免疫調節劑的聯苯類化合物的鹽型、晶型及其製備方法 |
CN116903595B (zh) * | 2023-06-01 | 2024-02-13 | 遵义医科大学珠海校区 | 一种嘧啶二酮类化合物及其制备方法和应用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018106850A1 (en) * | 2016-12-07 | 2018-06-14 | Auspex Pharmaceuticals, Inc. | Deuterated aminopyridine compounds |
HUE060233T2 (hu) * | 2016-12-22 | 2023-02-28 | Incyte Corp | Tetrahidro imidazo[4,5-c]piridin-származékok mint a PD-L1 internalizációját indukáló szerek |
TWI821288B (zh) * | 2018-05-11 | 2023-11-11 | 美商英塞特公司 | 作為免疫調節劑之雜環化合物 |
CN109020958A (zh) * | 2018-08-28 | 2018-12-18 | 湖南华腾制药有限公司 | 一种氘代色氨酸羟化酶抑制剂 |
-
2022
- 2022-01-27 AU AU2022214735A patent/AU2022214735A1/en active Pending
- 2022-01-27 JP JP2023546481A patent/JP2024505972A/ja active Pending
- 2022-01-27 WO PCT/CN2022/074183 patent/WO2022161421A1/zh active Application Filing
- 2022-01-27 CN CN202280008146.3A patent/CN116710445A/zh active Pending
- 2022-01-27 CA CA3210314A patent/CA3210314A1/en active Pending
- 2022-01-27 MX MX2023009052A patent/MX2023009052A/es unknown
- 2022-01-27 EP EP22745294.3A patent/EP4286383A1/en active Pending
- 2022-01-27 BR BR112023015451A patent/BR112023015451A2/pt unknown
- 2022-01-27 TW TW111103671A patent/TWI814226B/zh active
- 2022-01-27 KR KR1020237029267A patent/KR20230141812A/ko unknown
Also Published As
Publication number | Publication date |
---|---|
BR112023015451A2 (pt) | 2023-10-10 |
CA3210314A1 (en) | 2022-08-04 |
TW202237602A (zh) | 2022-10-01 |
CN116710445A (zh) | 2023-09-05 |
TWI814226B (zh) | 2023-09-01 |
WO2022161421A1 (zh) | 2022-08-04 |
EP4286383A1 (en) | 2023-12-06 |
JP2024505972A (ja) | 2024-02-08 |
AU2022214735A1 (en) | 2023-08-31 |
KR20230141812A (ko) | 2023-10-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2023009052A (es) | Compuesto de bifenilo como inmunomodulador, método de preparación para el mismo y uso del mismo. | |
NO2020026I1 (no) | Raltegravir eller et farmasøytisk akseptabelt salt derav, spesielt kaliumsaltet | |
DE60236541D1 (de) | Inhibitoren von 11-beta-hydroxysteroiddehydrogenase typ 1 | |
GB0112348D0 (en) | Compounds | |
PL369108A1 (en) | 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases | |
ATE381537T1 (de) | Formanilid-derivative als beta2-adrenorezeptor- agonisten | |
ATE370948T1 (de) | Hydroxynaphthyridinoncarbonsäureamide, die sich als inhibitoren der hiv-integrase eignen | |
BR0309343A (pt) | Composto, composição farmacêutica, uso de um composto, e, método de tratamento ou profilaxia de doenças ou condições humanas | |
BR0309342A (pt) | Composto, composição farmacêutica, uso de um composto, e, método de tratamento ou profilaxia de doenças ou condições humanas | |
RS41104A (en) | Sulphonamide derivatives, the preparation thereof and the application of same as medicaments | |
WO2005120516A3 (en) | Hiv integrase inhibitors | |
MX2023003846A (es) | Compuesto de bifenilo como inmunomodulador, metodo de preparacion del mismo y aplicacion del mismo. | |
MX2023006504A (es) | Compuesto de hidroxamato, metodo de preparacion del mismo y aplicacion del mismo. | |
DE60306546D1 (de) | Entzündungshemmende 3-arylthio-3-thiazolylalkylamine | |
TW200640465A (en) | New pharmaceutically active compounds for the treatment of respiratory diseases | |
AU2006299042A8 (en) | HIV integrase inhibitors | |
ATE409187T1 (de) | N-(substituierte benzyl)-8-hydroxy-1,6- naphthyridin-7- carbonsäureamide als hiv- integrase-hemmer | |
WO2021046315A3 (en) | Inhibitors of encephalitic alphaviruses | |
ATE404563T1 (de) | 8-hydroxy-1- oxotetrahydropyrrolopyrazinverbindungen, die sich als inhibitoren von hiv-integrase eignen | |
NO20053876L (no) | Karbonylaminosubstituerte acylfenylurederivater, fremgangsmate for deres fremstilling samt anvendelse derav | |
WO2005082862A3 (en) | Benzimidazolyl derivatives as kinase inhibitors | |
MXPA04005033A (es) | Composicion farmaceutica que comprende una combinacion de metformina y acido 4-oxobutanoico y el uso de la misma para el tratamiento contra diabetes. | |
BR9908452A (pt) | Composição fungicida que compreende uma benzoilfeniluréia | |
BRPI0415964A (pt) | uso de um composto, composto, formulação farmacêutica, e, processo para preparar um composto | |
SE0102640D0 (sv) | Novel compounds |